Nearly all the patients with severe sickle cell disease (SCD) who were treated with renizgamglogene autogedtemcel (reni-cel) remained free…
Articles by Andrea Lobo, PhD
Etavopivat, Novo Nordisk’s investigational oral therapy for sickle cell disease (SCD), may reduce the incidence of vaso-occlusive…
A hospital with the University of Rochester’s Medical Center has received a multi-million-dollar grant to conduct a study comparing the…
AB Science said it received a notice of allowance from the European Patent Office for a patent covering the use…
A Nigerian hematologist will pursue a PhD in health policy at the University of Tennessee Health Science Center to help…
Sigma Gamma Rho Sorority, a national collegiate women’s organization, has committed to raising $2 million by 2028 to…
Reproductive health issues were found to be common after a stem cell transplant among young people with sickle cell…
The use of eculizumab, an immunosuppressive medication approved for several autoimmune diseases, was found to be safe and effective for…
Emmaus Life Sciences, which markets Endari (L-glutamine) for sickle cell disease (SCD), has announced that it is complying…
The probability of developing organ and tissue damage — including in the lungs, kidneys, or eyes — increases as teenagers…